CORETTA THURMAN: Open Payments
NPI 1346684966 · STAUNTON, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$457 in 20 payments from 8 companies in 2025. Trend: 2023 $66 · 2024 $179 · 2025 $457
Food & beverage: $457
| Company | Payments | Amount |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 5 | $167 |
| Janssen Pharmaceuticals, Inc | 3 | $83 |
| Neurocrine BioSciences, Inc. | 3 | $59 |
| Alkermes, Inc. | 4 | $52 |
| ABBVIE INC. | 2 | $44 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $22 |
| Braeburn Inc. | 1 | $17 |
| Collegium Pharmaceutical, Inc. | 1 | $14 |
Products named: REXULTI, INVEGA SUSTENNA, INGREZZA, ARISTADA, VRAYLAR, ABILIFY ASIMTUFII, CAPLYTA, BRIXADI.
Industry payments across VA — which companies pay providers there.
